Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Alector reports Q2 EPS (58c), consensus (49c) » 16:22
08/11/20
08/11
16:22
08/11/20
16:22
ALEC

Alector

$14.35 /

-0.15 (-1.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALEC Alector
$14.35 /

-0.15 (-1.03%)

ALEC Alector
$14.35 /

-0.15 (-1.03%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
ALEC Alector
$14.35 /

-0.15 (-1.03%)

  • 15
    Jul
  • 30
    Jan
ALEC Alector
$14.35 /

-0.15 (-1.03%)

Over a week ago
Conference/Events
Alzheimer's Association to hold a virtual conference » 04:55
07/31/20
07/31
04:55
07/31/20
04:55
ABBV

AbbVie

$96.00 /

-0.955 (-0.98%)

, ACAD

Acadia

$42.48 /

-0.08 (-0.19%)

, ALEC

Alector

$16.71 /

+0.46 (+2.83%)

, BIIB

Biogen

$274.83 /

-2.66 (-0.96%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$152.95 /

-8.87 (-5.48%)

, MRK

Merck

$79.05 /

-0.28 (-0.35%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Alzheimer's…

Alzheimer's Association International Virtual Conference: AAIC Virtual 2020 will be held on July 27-31. Webcast Link

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.05 /

-0.28 (-0.35%)

LLY Eli Lilly
$152.95 /

-8.87 (-5.48%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$274.83 /

-2.66 (-0.96%)

ALEC Alector
$16.71 /

+0.46 (+2.83%)

ACAD Acadia
$42.48 /

-0.08 (-0.19%)

ABBV AbbVie
$96.00 /

-0.955 (-0.98%)

ABBV AbbVie
$96.00 /

-0.955 (-0.98%)

07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 Piper Sandler
Biohaven migraine competitor shows constipation signal, says Piper Sandler
07/27/20 H.C. Wainwright
Agreement termination 'optimal' for Vyleesi future, says H.C. Wainwright
07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
ACAD Acadia
$42.48 /

-0.08 (-0.19%)

07/27/20 Canaccord
Acadia pullback a buying opportunity, says Canaccord
07/21/20 Oppenheimer
Acadia price target lowered to $42 from $53 at Oppenheimer
07/21/20 RBC Capital
Acadia price target lowered to $55 from $61 at RBC Capital
07/21/20 Citi
Acadia price target lowered to $63 from $69 at Citi
ALEC Alector
$16.71 /

+0.46 (+2.83%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
BIIB Biogen
$274.83 /

-2.66 (-0.96%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
07/27/20 Morgan Stanley
Biogen upgraded to Overweight from Underweight at Morgan Stanley
07/23/20 BMO Capital
Biogen price target lowered to $280 from $317 at BMO Capital
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
08/05/19 Citi
Eisai upgraded to Neutral from Sell at Citi
LLY Eli Lilly
$152.95 /

-8.87 (-5.48%)

07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
MRK Merck
$79.05 /

-0.28 (-0.35%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.05 /

-0.28 (-0.35%)

LLY Eli Lilly
$152.95 /

-8.87 (-5.48%)

BIIB Biogen
$274.83 /

-2.66 (-0.96%)

ALEC Alector
$16.71 /

+0.46 (+2.83%)

ACAD Acadia
$42.48 /

-0.08 (-0.19%)

ABBV AbbVie
$96.00 /

-0.955 (-0.98%)

  • 15
    Jul
  • 30
    Jan
  • 18
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.05 /

-0.28 (-0.35%)

LLY Eli Lilly
$152.95 /

-8.87 (-5.48%)

BIIB Biogen
$274.83 /

-2.66 (-0.96%)

ABBV AbbVie
$96.00 /

-0.955 (-0.98%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.05 /

-0.28 (-0.35%)

LLY Eli Lilly
$152.95 /

-8.87 (-5.48%)

BIIB Biogen
$274.83 /

-2.66 (-0.96%)

ALEC Alector
$16.71 /

+0.46 (+2.83%)

ACAD Acadia
$42.48 /

-0.08 (-0.19%)

ABBV AbbVie
$96.00 /

-0.955 (-0.98%)

MRK Merck
$79.05 /

-0.28 (-0.35%)

LLY Eli Lilly
$152.95 /

-8.87 (-5.48%)

BIIB Biogen
$274.83 /

-2.66 (-0.96%)

ABBV AbbVie
$96.00 /

-0.955 (-0.98%)

Conference/Events
Alzheimer's Association to hold a virtual conference » 04:55
07/30/20
07/30
04:55
07/30/20
04:55
ABBV

AbbVie

$96.96 /

+0.205 (+0.21%)

, ACAD

Acadia

$42.56 /

-0.59 (-1.37%)

, ALEC

Alector

$16.25 /

-5.08 (-23.82%)

, BIIB

Biogen

$277.49 /

-2.99 (-1.07%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$161.82 /

-0.875 (-0.54%)

, MRK

Merck

$79.33 /

-0.4 (-0.50%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Alzheimer's…

Alzheimer's Association International Virtual Conference: AAIC Virtual 2020 will be held on July 27-31. Webcast Link

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.33 /

-0.4 (-0.50%)

LLY Eli Lilly
$161.82 /

-0.875 (-0.54%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$277.49 /

-2.99 (-1.07%)

ALEC Alector
$16.25 /

-5.08 (-23.82%)

ACAD Acadia
$42.56 /

-0.59 (-1.37%)

ABBV AbbVie
$96.96 /

+0.205 (+0.21%)

ABBV AbbVie
$96.96 /

+0.205 (+0.21%)

07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 Piper Sandler
Biohaven migraine competitor shows constipation signal, says Piper Sandler
07/27/20 H.C. Wainwright
Agreement termination 'optimal' for Vyleesi future, says H.C. Wainwright
07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
ACAD Acadia
$42.56 /

-0.59 (-1.37%)

07/27/20 Canaccord
Acadia pullback a buying opportunity, says Canaccord
07/21/20 Oppenheimer
Acadia price target lowered to $42 from $53 at Oppenheimer
07/21/20 RBC Capital
Acadia price target lowered to $55 from $61 at RBC Capital
07/21/20 Citi
Acadia price target lowered to $63 from $69 at Citi
ALEC Alector
$16.25 /

-5.08 (-23.82%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
BIIB Biogen
$277.49 /

-2.99 (-1.07%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
07/27/20 Morgan Stanley
Biogen upgraded to Overweight from Underweight at Morgan Stanley
07/23/20 BMO Capital
Biogen price target lowered to $280 from $317 at BMO Capital
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
08/05/19 Citi
Eisai upgraded to Neutral from Sell at Citi
LLY Eli Lilly
$161.82 /

-0.875 (-0.54%)

07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
MRK Merck
$79.33 /

-0.4 (-0.50%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.33 /

-0.4 (-0.50%)

LLY Eli Lilly
$161.82 /

-0.875 (-0.54%)

BIIB Biogen
$277.49 /

-2.99 (-1.07%)

ALEC Alector
$16.25 /

-5.08 (-23.82%)

ACAD Acadia
$42.56 /

-0.59 (-1.37%)

ABBV AbbVie
$96.96 /

+0.205 (+0.21%)

  • 15
    Jul
  • 30
    Jan
  • 18
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.33 /

-0.4 (-0.50%)

LLY Eli Lilly
$161.82 /

-0.875 (-0.54%)

BIIB Biogen
$277.49 /

-2.99 (-1.07%)

ABBV AbbVie
$96.96 /

+0.205 (+0.21%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.33 /

-0.4 (-0.50%)

LLY Eli Lilly
$161.82 /

-0.875 (-0.54%)

BIIB Biogen
$277.49 /

-2.99 (-1.07%)

ALEC Alector
$16.25 /

-5.08 (-23.82%)

ACAD Acadia
$42.56 /

-0.59 (-1.37%)

ABBV AbbVie
$96.96 /

+0.205 (+0.21%)

MRK Merck
$79.33 /

-0.4 (-0.50%)

LLY Eli Lilly
$161.82 /

-0.875 (-0.54%)

BIIB Biogen
$277.49 /

-2.99 (-1.07%)

ABBV AbbVie
$96.96 /

+0.205 (+0.21%)

On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:59
07/29/20
07/29
16:59
07/29/20
16:59
BA

Boeing

$165.99 /

-4.92 (-2.88%)

, GM

General Motors

$25.89 /

-0.46 (-1.75%)

, GE

General Electric

$6.59 /

-0.31 (-4.50%)

, SBUX

Starbucks

$77.42 /

+2.65 (+3.54%)

, V

Visa

$198.61 /

+1.525 (+0.77%)

, FB

Facebook

$233.32 /

+3.31 (+1.44%)

, GOOG

Alphabet

$1,521.18 /

+20.71 (+1.38%)

, GOOGL

Alphabet Class A

$1,521.86 /

+17.66 (+1.17%)

, AMZN

Amazon.com

$3,033.27 /

+30.51 (+1.02%)

, AAPL

Apple

$380.23 /

+7.22 (+1.94%)

, AMD

AMD

$76.10 /

+8.34 (+12.31%)

, TUP

Tupperware Brands

$16.15 /

+6.51 (+67.53%)

, CYH

Community Health

$4.50 /

+0.375 (+9.09%)

, SHOP

Shopify

$1,050.09 /

+66.34 (+6.74%)

, ALEC

Alector

$16.25 /

-5.08 (-23.82%)

, STX

Seagate

$44.31 /

-4.585 (-9.38%)

, IMAX

IMAX

$11.19 /

-1.36 (-10.84%)

, SPOT

Spotify

$262.06 /

-5.355 (-2.00%)

The major averages were…

Open Full Text

ShowHide Related Items >><<
V Visa
$198.61 /

+1.525 (+0.77%)

TUP Tupperware Brands
$16.15 /

+6.51 (+67.53%)

STX Seagate
$44.31 /

-4.585 (-9.38%)

SPOT Spotify
$262.06 /

-5.355 (-2.00%)

SHOP Shopify
$1,050.09 /

+66.34 (+6.74%)

SBUX Starbucks
$77.42 /

+2.65 (+3.54%)

IMAX IMAX
$11.19 /

-1.36 (-10.84%)

GOOGL Alphabet Class A
$1,521.86 /

+17.66 (+1.17%)

GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

GM General Motors
$25.89 /

-0.46 (-1.75%)

GE General Electric
$6.59 /

-0.31 (-4.50%)

FB Facebook
$233.32 /

+3.31 (+1.44%)

CYH Community Health
$4.50 /

+0.375 (+9.09%)

BA Boeing
$165.99 /

-4.92 (-2.88%)

AMZN Amazon.com
$3,033.27 /

+30.51 (+1.02%)

AMD AMD
$76.10 /

+8.34 (+12.31%)

ALEC Alector
$16.25 /

-5.08 (-23.82%)

AAPL Apple
$380.23 /

+7.22 (+1.94%)

BA Boeing
$165.99 /

-4.92 (-2.88%)

07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
07/16/20 Wolfe Research
Boeing downgraded to Underperform from Peer Perform at Wolfe Research
GM General Motors
$25.89 /

-0.46 (-1.75%)

07/30/20 Deutsche Bank
General Motors price target raised to $33 from $30 at Deutsche Bank
06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
GE General Electric
$6.59 /

-0.31 (-4.50%)

06/05/20 Citi
Recovery at GE Healthcare is underway, says Citi
06/03/20 JPMorgan
Raytheon presentation indicates GE estimates not 'reset,' says JPMorgan
04/30/20 William Blair
GE business remains solid despite big 2020 challenges, says William Blair
04/30/20 Credit Suisse
General Electric price target lowered to $8 from $9 at Credit Suisse
SBUX Starbucks
$77.42 /

+2.65 (+3.54%)

07/29/20 Stephens
Starbucks price target raised to $78 from $72 at Stephens
07/29/20 Jefferies
Starbucks recovery in U.S. 'a bit ahead of plan,' says Jefferies
07/29/20 MKM Partners
Starbucks price target raised to $79 from $74 at MKM Partners
07/29/20 Wedbush
Starbucks price target raised to $81 from $75 at Wedbush
V Visa
$198.61 /

+1.525 (+0.77%)

07/20/20 Goldman Sachs
PayPal price target raised to $205 from $170 at Goldman Sachs
07/14/20 Goldman Sachs
Visa initiated with a Buy at Goldman Sachs
07/13/20 Wells Fargo
Visa price target raised to $220 from $205 at Wells Fargo
07/09/20 JPMorgan
Visa price target raised to $203 from $182 at JPMorgan
FB Facebook
$233.32 /

+3.31 (+1.44%)

07/28/20 Deutsche Bank
Facebook price target raised to $275 from $220 at Deutsche Bank
07/28/20 Mizuho
Facebook price target raised to $270 from $245 at Mizuho
07/27/20 Stifel
Stifel sees strong user and engagement metrics, cautious outlook from Facebook
07/27/20 Wedbush
Facebook Q2 audience upside to be tempered by weaker ad backdrop, says Wedbush
GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

07/28/20 JPMorgan
Alphabet shares worth $2,000 on sum-of-the-parts, says JPMorgan
07/28/20 Deutsche Bank
Alphabet price target raised to $1,975 from $1,700 at Deutsche Bank
07/27/20 Wells Fargo
Alphabet price target raised to $1,750 from $1,575 at Wells Fargo
07/27/20 Wedbush
Wedbush sees potential Q2 top-line weakness for Alphabet due to Search headwinds
GOOGL Alphabet Class A
$1,521.86 /

+17.66 (+1.17%)

07/29/20 BMO Capital
Alphabet price target raised to $1,750 from $1,550 at BMO Capital
AMZN Amazon.com
$3,033.27 /

+30.51 (+1.02%)

07/30/20 BMO Capital
Amazon.com price target raised to $3,500 from $2,850 at BMO Capital
07/28/20 Jefferies
Amazon.com set to deliver on high expectations, says Jefferies
07/27/20 Wells Fargo
Amazon.com price target raised to $3,600 from $3,000 at Wells Fargo
07/27/20 Wedbush
Amazon.com price target raised to $3,500 from $3,050 at Wedbush
AAPL Apple
$380.23 /

+7.22 (+1.94%)

07/30/20 Berenberg
Activision Blizzard price target raised to $88 from $83 at Berenberg
07/29/20 Credit Suisse
Apple price target raised to $340 from $295 at Credit Suisse
07/28/20 Wedbush
All eyes on Apple's iPhone 12 launch into the Fall, says Wedbush
07/28/20 Deutsche Bank
Deutsche Bank sees 'high bar' into upcoming Apple results
AMD AMD
$76.10 /

+8.34 (+12.31%)

07/29/20
Fly Intel: Top five analyst downgrades
07/29/20
Fly Intel: Top five analyst upgrades
07/29/20 JPMorgan
AMD price target raised to $62 from $52 at JPMorgan
07/29/20 Exane BNP Paribas
AMD upgraded to Outperform from Neutral at Exane BNP Paribas
TUP Tupperware Brands
$16.15 /

+6.51 (+67.53%)

06/02/20 Sidoti
Tupperware Brands initiated with a Buy at Sidoti
12/04/19 Citi
Tupperware Brands assumed with a Neutral at Citi
CYH Community Health
$4.50 /

+0.375 (+9.09%)

06/11/20 Citi
Community Health price target raised to $3.50 from $3.00 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
02/24/20 RBC Capital
Community Health price target raised to $8 from $4 at RBC Capital
02/20/20 Raymond James
Community Health upgraded at Raymond James as near-term pressures limited
SHOP Shopify
$1,050.09 /

+66.34 (+6.74%)

07/30/20 DA Davidson
Shopify price target raised to $1,000 from $650 at DA Davidson
07/30/20 Truist
Shopify price target raised to $1,100 from $700 at SunTrust
07/30/20 KeyBanc
Shopify price target raised to $1,150 from $1,125 at KeyBanc
07/30/20 Goldman Sachs
Shopify price target raised to $1,286 from $1,127 at Goldman Sachs
ALEC Alector
$16.25 /

-5.08 (-23.82%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
STX Seagate
$44.31 /

-4.585 (-9.38%)

07/29/20 Stifel
Stifel trims Seagate price target to $63, says cloud thesis intact
07/29/20 Wells Fargo
Seagate price target lowered to $50 from $55 at Wells Fargo
07/29/20 Cross Research
Seagate downgraded to Hold from Buy at Cross Research
IMAX IMAX
$11.19 /

-1.36 (-10.84%)

07/29/20 Canaccord
IMAX price target lowered to $14.50 from $16 at Canaccord
07/15/20 Goldman Sachs
Imax initiated with a Buy at Goldman Sachs
07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
04/28/20
Fly Intel: Top five analyst upgrades
SPOT Spotify
$262.06 /

-5.355 (-2.00%)

07/30/20 Loop Capital
Spotify price target raised to $200 from $150 at Loop Capital
07/30/20 Deutsche Bank
Spotify price target raised to $240 from $144 at Deutsche Bank
07/27/20 Stifel
Spotify price target raised to $305 from $185 at Stifel
07/16/20 Credit Suisse
Spotify price target raised to $215 from $130 at Credit Suisse
V Visa
$198.61 /

+1.525 (+0.77%)

TUP Tupperware Brands
$16.15 /

+6.51 (+67.53%)

STX Seagate
$44.31 /

-4.585 (-9.38%)

SPOT Spotify
$262.06 /

-5.355 (-2.00%)

SHOP Shopify
$1,050.09 /

+66.34 (+6.74%)

SBUX Starbucks
$77.42 /

+2.65 (+3.54%)

IMAX IMAX
$11.19 /

-1.36 (-10.84%)

GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

GM General Motors
$25.89 /

-0.46 (-1.75%)

GE General Electric
$6.59 /

-0.31 (-4.50%)

FB Facebook
$233.32 /

+3.31 (+1.44%)

CYH Community Health
$4.50 /

+0.375 (+9.09%)

BA Boeing
$165.99 /

-4.92 (-2.88%)

AMZN Amazon.com
$3,033.27 /

+30.51 (+1.02%)

AMD AMD
$76.10 /

+8.34 (+12.31%)

ALEC Alector
$16.25 /

-5.08 (-23.82%)

AAPL Apple
$380.23 /

+7.22 (+1.94%)

  • 15
    Jul
  • 08
    May
  • 30
    Jan
  • 17
    Sep
V Visa
$198.61 /

+1.525 (+0.77%)

STX Seagate
$44.31 /

-4.585 (-9.38%)

SPOT Spotify
$262.06 /

-5.355 (-2.00%)

SHOP Shopify
$1,050.09 /

+66.34 (+6.74%)

SBUX Starbucks
$77.42 /

+2.65 (+3.54%)

IMAX IMAX
$11.19 /

-1.36 (-10.84%)

GOOGL Alphabet Class A
$1,521.86 /

+17.66 (+1.17%)

GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

GM General Motors
$25.89 /

-0.46 (-1.75%)

GE General Electric
$6.59 /

-0.31 (-4.50%)

FB Facebook
$233.32 /

+3.31 (+1.44%)

CYH Community Health
$4.50 /

+0.375 (+9.09%)

BA Boeing
$165.99 /

-4.92 (-2.88%)

AMZN Amazon.com
$3,033.27 /

+30.51 (+1.02%)

AMD AMD
$76.10 /

+8.34 (+12.31%)

AAPL Apple
$380.23 /

+7.22 (+1.94%)

TUP Tupperware Brands
$16.15 /

+6.51 (+67.53%)

STX Seagate
$44.31 /

-4.585 (-9.38%)

SPOT Spotify
$262.06 /

-5.355 (-2.00%)

SBUX Starbucks
$77.42 /

+2.65 (+3.54%)

IMAX IMAX
$11.19 /

-1.36 (-10.84%)

GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

GM General Motors
$25.89 /

-0.46 (-1.75%)

GE General Electric
$6.59 /

-0.31 (-4.50%)

FB Facebook
$233.32 /

+3.31 (+1.44%)

CYH Community Health
$4.50 /

+0.375 (+9.09%)

BA Boeing
$165.99 /

-4.92 (-2.88%)

AMD AMD
$76.10 /

+8.34 (+12.31%)

AAPL Apple
$380.23 /

+7.22 (+1.94%)

V Visa
$198.61 /

+1.525 (+0.77%)

TUP Tupperware Brands
$16.15 /

+6.51 (+67.53%)

STX Seagate
$44.31 /

-4.585 (-9.38%)

SPOT Spotify
$262.06 /

-5.355 (-2.00%)

SHOP Shopify
$1,050.09 /

+66.34 (+6.74%)

SBUX Starbucks
$77.42 /

+2.65 (+3.54%)

GOOGL Alphabet Class A
$1,521.86 /

+17.66 (+1.17%)

GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

GM General Motors
$25.89 /

-0.46 (-1.75%)

GE General Electric
$6.59 /

-0.31 (-4.50%)

FB Facebook
$233.32 /

+3.31 (+1.44%)

CYH Community Health
$4.50 /

+0.375 (+9.09%)

BA Boeing
$165.99 /

-4.92 (-2.88%)

AMZN Amazon.com
$3,033.27 /

+30.51 (+1.02%)

AMD AMD
$76.10 /

+8.34 (+12.31%)

AAPL Apple
$380.23 /

+7.22 (+1.94%)

GOOGL Alphabet Class A
$1,521.86 /

+17.66 (+1.17%)

GOOG Alphabet
$1,521.18 /

+20.71 (+1.38%)

AMZN Amazon.com
$3,033.27 /

+30.51 (+1.02%)

AAPL Apple
$380.23 /

+7.22 (+1.94%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:21
07/29/20
07/29
12:21
07/29/20
12:21
BA

Boeing

$165.80 /

-5.11 (-2.99%)

, GM

General Motors

$25.66 /

-0.69 (-2.62%)

, GE

General Electric

$6.56 /

-0.34 (-4.93%)

, V

Visa

$195.67 /

-1.41 (-0.72%)

, SBUX

Starbucks

$77.48 /

+2.71 (+3.62%)

, AMD

AMD

$76.38 /

+8.62 (+12.72%)

, TUP

Tupperware Brands

$15.07 /

+5.43 (+56.33%)

, CYH

Community Health

$4.57 /

+0.445 (+10.79%)

, SHOP

Shopify

$1,071.18 /

+87.43 (+8.89%)

, ALEC

Alector

$14.96 /

-6.375 (-29.89%)

, IMAX

IMAX

$11.44 /

-1.11 (-8.84%)

, SPOT

Spotify

$262.05 /

-5.36 (-2.00%)

, STX

Seagate

$43.76 /

-5.13 (-10.49%)

The major averages are…

Open Full Text

ShowHide Related Items >><<
V Visa
$195.67 /

-1.41 (-0.72%)

TUP Tupperware Brands
$15.07 /

+5.43 (+56.33%)

STX Seagate
$43.76 /

-5.13 (-10.49%)

SPOT Spotify
$262.05 /

-5.36 (-2.00%)

SHOP Shopify
$1,071.18 /

+87.43 (+8.89%)

SBUX Starbucks
$77.48 /

+2.71 (+3.62%)

IMAX IMAX
$11.44 /

-1.11 (-8.84%)

GM General Motors
$25.66 /

-0.69 (-2.62%)

GE General Electric
$6.56 /

-0.34 (-4.93%)

CYH Community Health
$4.57 /

+0.445 (+10.79%)

BA Boeing
$165.80 /

-5.11 (-2.99%)

AMD AMD
$76.38 /

+8.62 (+12.72%)

ALEC Alector
$14.96 /

-6.375 (-29.89%)

BA Boeing
$165.80 /

-5.11 (-2.99%)

07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
07/16/20 Wolfe Research
Boeing downgraded to Underperform from Peer Perform at Wolfe Research
07/15/20 Truist
SunTrust downgrades select commercial aviation supply stocks
07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
GM General Motors
$25.66 /

-0.69 (-2.62%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
GE General Electric
$6.56 /

-0.34 (-4.93%)

06/05/20 Citi
Recovery at GE Healthcare is underway, says Citi
06/03/20 JPMorgan
Raytheon presentation indicates GE estimates not 'reset,' says JPMorgan
04/30/20 William Blair
GE business remains solid despite big 2020 challenges, says William Blair
04/30/20 Credit Suisse
General Electric price target lowered to $8 from $9 at Credit Suisse
V Visa
$195.67 /

-1.41 (-0.72%)

07/20/20 Goldman Sachs
PayPal price target raised to $205 from $170 at Goldman Sachs
07/14/20 Goldman Sachs
Visa initiated with a Buy at Goldman Sachs
07/13/20 Wells Fargo
Visa price target raised to $220 from $205 at Wells Fargo
07/09/20 JPMorgan
Visa price target raised to $203 from $182 at JPMorgan
SBUX Starbucks
$77.48 /

+2.71 (+3.62%)

07/29/20 Stephens
Starbucks price target raised to $78 from $72 at Stephens
07/29/20 Jefferies
Starbucks recovery in U.S. 'a bit ahead of plan,' says Jefferies
07/29/20 MKM Partners
Starbucks price target raised to $79 from $74 at MKM Partners
07/29/20 Wedbush
Starbucks price target raised to $81 from $75 at Wedbush
AMD AMD
$76.38 /

+8.62 (+12.72%)

07/29/20
Fly Intel: Top five analyst downgrades
07/29/20
Fly Intel: Top five analyst upgrades
07/29/20 JPMorgan
AMD price target raised to $62 from $52 at JPMorgan
07/29/20 Exane BNP Paribas
AMD upgraded to Outperform from Neutral at Exane BNP Paribas
TUP Tupperware Brands
$15.07 /

+5.43 (+56.33%)

06/02/20 Sidoti
Tupperware Brands initiated with a Buy at Sidoti
12/04/19 Citi
Tupperware Brands assumed with a Neutral at Citi
CYH Community Health
$4.57 /

+0.445 (+10.79%)

06/11/20 Citi
Community Health price target raised to $3.50 from $3.00 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
02/24/20 RBC Capital
Community Health price target raised to $8 from $4 at RBC Capital
02/20/20 Raymond James
Community Health upgraded at Raymond James as near-term pressures limited
SHOP Shopify
$1,071.18 /

+87.43 (+8.89%)

07/29/20 Piper Sandler
Shopify price target raised to $1,300 from $1,015 at Piper Sandler
07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Goldman Sachs
Shopify upgraded to Buy from Neutral at Goldman Sachs
07/28/20 Jefferies
Shopify price target raised to $1,120 from $725 at Jefferies
ALEC Alector
$14.96 /

-6.375 (-29.89%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
IMAX IMAX
$11.44 /

-1.11 (-8.84%)

07/29/20 Canaccord
IMAX price target lowered to $14.50 from $16 at Canaccord
07/15/20 Goldman Sachs
Imax initiated with a Buy at Goldman Sachs
07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
04/28/20
Fly Intel: Top five analyst upgrades
SPOT Spotify
$262.05 /

-5.36 (-2.00%)

07/27/20 Stifel
Spotify price target raised to $305 from $185 at Stifel
07/16/20 Credit Suisse
Spotify price target raised to $215 from $130 at Credit Suisse
07/15/20 Truist
Spotify price target raised to $290 from $167 at SunTrust
07/14/20
Fly Intel: Top five analyst downgrades
STX Seagate
$43.76 /

-5.13 (-10.49%)

07/29/20 Stifel
Stifel trims Seagate price target to $63, says cloud thesis intact
07/29/20 Wells Fargo
Seagate price target lowered to $50 from $55 at Wells Fargo
07/29/20 Cross Research
Seagate downgraded to Hold from Buy at Cross Research
V Visa
$195.67 /

-1.41 (-0.72%)

TUP Tupperware Brands
$15.07 /

+5.43 (+56.33%)

STX Seagate
$43.76 /

-5.13 (-10.49%)

SPOT Spotify
$262.05 /

-5.36 (-2.00%)

SHOP Shopify
$1,071.18 /

+87.43 (+8.89%)

SBUX Starbucks
$77.48 /

+2.71 (+3.62%)

IMAX IMAX
$11.44 /

-1.11 (-8.84%)

GM General Motors
$25.66 /

-0.69 (-2.62%)

GE General Electric
$6.56 /

-0.34 (-4.93%)

CYH Community Health
$4.57 /

+0.445 (+10.79%)

BA Boeing
$165.80 /

-5.11 (-2.99%)

AMD AMD
$76.38 /

+8.62 (+12.72%)

ALEC Alector
$14.96 /

-6.375 (-29.89%)

  • 15
    Jul
  • 08
    May
  • 30
    Jan
  • 17
    Sep
V Visa
$195.67 /

-1.41 (-0.72%)

STX Seagate
$43.76 /

-5.13 (-10.49%)

SPOT Spotify
$262.05 /

-5.36 (-2.00%)

SHOP Shopify
$1,071.18 /

+87.43 (+8.89%)

SBUX Starbucks
$77.48 /

+2.71 (+3.62%)

IMAX IMAX
$11.44 /

-1.11 (-8.84%)

GM General Motors
$25.66 /

-0.69 (-2.62%)

GE General Electric
$6.56 /

-0.34 (-4.93%)

CYH Community Health
$4.57 /

+0.445 (+10.79%)

BA Boeing
$165.80 /

-5.11 (-2.99%)

AMD AMD
$76.38 /

+8.62 (+12.72%)

V Visa
$195.67 /

-1.41 (-0.72%)

TUP Tupperware Brands
$15.07 /

+5.43 (+56.33%)

STX Seagate
$43.76 /

-5.13 (-10.49%)

SPOT Spotify
$262.05 /

-5.36 (-2.00%)

SHOP Shopify
$1,071.18 /

+87.43 (+8.89%)

SBUX Starbucks
$77.48 /

+2.71 (+3.62%)

IMAX IMAX
$11.44 /

-1.11 (-8.84%)

GM General Motors
$25.66 /

-0.69 (-2.62%)

GE General Electric
$6.56 /

-0.34 (-4.93%)

CYH Community Health
$4.57 /

+0.445 (+10.79%)

BA Boeing
$165.80 /

-5.11 (-2.99%)

AMD AMD
$76.38 /

+8.62 (+12.72%)

V Visa
$195.67 /

-1.41 (-0.72%)

TUP Tupperware Brands
$15.07 /

+5.43 (+56.33%)

STX Seagate
$43.76 /

-5.13 (-10.49%)

SPOT Spotify
$262.05 /

-5.36 (-2.00%)

SHOP Shopify
$1,071.18 /

+87.43 (+8.89%)

SBUX Starbucks
$77.48 /

+2.71 (+3.62%)

GM General Motors
$25.66 /

-0.69 (-2.62%)

GE General Electric
$6.56 /

-0.34 (-4.93%)

CYH Community Health
$4.57 /

+0.445 (+10.79%)

BA Boeing
$165.80 /

-5.11 (-2.99%)

AMD AMD
$76.38 /

+8.62 (+12.72%)

Conference/Events
Alzheimer's Association to hold a virtual conference » 04:55
07/29/20
07/29
04:55
07/29/20
04:55
ABBV

AbbVie

$96.75 /

-0.38 (-0.39%)

, ACAD

Acadia

$43.15 /

-1.17 (-2.64%)

, ALEC

Alector

$21.33 /

-2.05 (-8.77%)

, BIIB

Biogen

$280.48 /

-5.6 (-1.96%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$162.70 /

+2.065 (+1.29%)

, MRK

Merck

$79.73 /

+0.8 (+1.01%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Alzheimer's…

Alzheimer's Association International Virtual Conference: AAIC Virtual 2020 will be held on July 27-31. Webcast Link

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.73 /

+0.8 (+1.01%)

LLY Eli Lilly
$162.70 /

+2.065 (+1.29%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$280.48 /

-5.6 (-1.96%)

ALEC Alector
$21.33 /

-2.05 (-8.77%)

ACAD Acadia
$43.15 /

-1.17 (-2.64%)

ABBV AbbVie
$96.75 /

-0.38 (-0.39%)

ABBV AbbVie
$96.75 /

-0.38 (-0.39%)

07/27/20 H.C. Wainwright
Agreement termination 'optimal' for Vyleesi future, says H.C. Wainwright
07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
ACAD Acadia
$43.15 /

-1.17 (-2.64%)

07/27/20 Canaccord
Acadia pullback a buying opportunity, says Canaccord
07/21/20 Oppenheimer
Acadia price target lowered to $42 from $53 at Oppenheimer
07/21/20 RBC Capital
Acadia price target lowered to $55 from $61 at RBC Capital
07/21/20 Citi
Acadia price target lowered to $63 from $69 at Citi
ALEC Alector
$21.33 /

-2.05 (-8.77%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
BIIB Biogen
$280.48 /

-5.6 (-1.96%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
07/27/20 Morgan Stanley
Biogen upgraded to Overweight from Underweight at Morgan Stanley
07/23/20 BMO Capital
Biogen price target lowered to $280 from $317 at BMO Capital
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
08/05/19 Citi
Eisai upgraded to Neutral from Sell at Citi
LLY Eli Lilly
$162.70 /

+2.065 (+1.29%)

07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
MRK Merck
$79.73 /

+0.8 (+1.01%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
RHHBY Roche
$0.00 /

+ (+0.00%)

07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
07/24/20 Barclays
Barclays backs Overweight on Roche after 'soft' Q2
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.73 /

+0.8 (+1.01%)

LLY Eli Lilly
$162.70 /

+2.065 (+1.29%)

BIIB Biogen
$280.48 /

-5.6 (-1.96%)

ALEC Alector
$21.33 /

-2.05 (-8.77%)

ACAD Acadia
$43.15 /

-1.17 (-2.64%)

ABBV AbbVie
$96.75 /

-0.38 (-0.39%)

  • 15
    Jul
  • 30
    Jan
  • 18
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.73 /

+0.8 (+1.01%)

LLY Eli Lilly
$162.70 /

+2.065 (+1.29%)

BIIB Biogen
$280.48 /

-5.6 (-1.96%)

ABBV AbbVie
$96.75 /

-0.38 (-0.39%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$79.73 /

+0.8 (+1.01%)

LLY Eli Lilly
$162.70 /

+2.065 (+1.29%)

BIIB Biogen
$280.48 /

-5.6 (-1.96%)

ACAD Acadia
$43.15 /

-1.17 (-2.64%)

ABBV AbbVie
$96.75 /

-0.38 (-0.39%)

MRK Merck
$79.73 /

+0.8 (+1.01%)

LLY Eli Lilly
$162.70 /

+2.065 (+1.29%)

BIIB Biogen
$280.48 /

-5.6 (-1.96%)

ABBV AbbVie
$96.75 /

-0.38 (-0.39%)

Hot Stocks
Alector reports 'promising' preliminary data from AL001 Ph. 1b, Phase 2 studies » 18:01
07/28/20
07/28
18:01
07/28/20
18:01
ALEC

Alector

$21.33 /

-2.05 (-8.77%)

Alector announced…

Alector announced preliminary data from its Phase 1b and open-label Phase 2 studies of AL001, for the treatment of people with frontotemporal dementia with a progranulin gene mutation. AL001 is the company's wholly owned, investigational human monoclonal antibody designed to modulate progranulin, a key regulator of immune activity in the brain. The data were presented today at the virtual 2020 Alzheimer's Association International Conference by Robert Paul, M.D., Ph.D., chief medical officer of Alector. Frontotemporal dementia is a rapidly progressing and severe form of dementia found most frequently in people less than 65 years old at the time of diagnosis. There are multiple heritable forms of FTD, and FTD-GRN represents 5% to 10% of all people with FTD. There are currently no FDA-approved treatment options for FTD. "We continue to discover and develop therapies in pursuit of our goal to eradicate neurodegenerative diseases," said Arnon Rosenthal, Ph.D., co-founder and chief executive officer of Alector. "The encouraging results from the Phase 1b and Phase 2 studies of AL001 represent substantial progress. With our rapid initiation of a pivotal Phase 3 trial, we hope that it is only a matter of time before AL001 is the first treatment option for people living with this devastating disease."

ShowHide Related Items >><<
ALEC Alector
$21.33 /

-2.05 (-8.77%)

ALEC Alector
$21.33 /

-2.05 (-8.77%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
ALEC Alector
$21.33 /

-2.05 (-8.77%)

  • 15
    Jul
  • 30
    Jan
Conference/Events
Alzheimer's Association to hold a virtual conference » 04:55
07/28/20
07/28
04:55
07/28/20
04:55
ABBV

AbbVie

$97.13 /

+0.17 (+0.18%)

, ACAD

Acadia

$44.32 /

+0.87 (+2.00%)

, ALEC

Alector

$23.38 /

+1.29 (+5.84%)

, BIIB

Biogen

$286.08 /

+13.75 (+5.05%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$160.63 /

+1.25 (+0.78%)

, MRK

Merck

$78.93 /

+1.82 (+2.36%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Alzheimer's…

Alzheimer's Association International Virtual Conference: AAIC Virtual 2020 will be held on July 27-31. Webcast Link

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$78.93 /

+1.82 (+2.36%)

LLY Eli Lilly
$160.63 /

+1.25 (+0.78%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$286.08 /

+13.75 (+5.05%)

ALEC Alector
$23.38 /

+1.29 (+5.84%)

ACAD Acadia
$44.32 /

+0.87 (+2.00%)

ABBV AbbVie
$97.13 /

+0.17 (+0.18%)

ABBV AbbVie
$97.13 /

+0.17 (+0.18%)

07/27/20 H.C. Wainwright
Agreement termination 'optimal' for Vyleesi future, says H.C. Wainwright
07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
ACAD Acadia
$44.32 /

+0.87 (+2.00%)

07/27/20 Canaccord
Acadia pullback a buying opportunity, says Canaccord
07/21/20 Oppenheimer
Acadia price target lowered to $42 from $53 at Oppenheimer
07/21/20 RBC Capital
Acadia price target lowered to $55 from $61 at RBC Capital
07/21/20 Citi
Acadia price target lowered to $63 from $69 at Citi
ALEC Alector
$23.38 /

+1.29 (+5.84%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
BIIB Biogen
$286.08 /

+13.75 (+5.05%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
07/27/20 Morgan Stanley
Biogen upgraded to Overweight from Underweight at Morgan Stanley
07/23/20 BMO Capital
Biogen price target lowered to $280 from $317 at BMO Capital
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
08/05/19 Citi
Eisai upgraded to Neutral from Sell at Citi
LLY Eli Lilly
$160.63 /

+1.25 (+0.78%)

07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
MRK Merck
$78.93 /

+1.82 (+2.36%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
RHHBY Roche
$0.00 /

+ (+0.00%)

07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
07/24/20 Barclays
Barclays backs Overweight on Roche after 'soft' Q2
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$78.93 /

+1.82 (+2.36%)

LLY Eli Lilly
$160.63 /

+1.25 (+0.78%)

BIIB Biogen
$286.08 /

+13.75 (+5.05%)

ALEC Alector
$23.38 /

+1.29 (+5.84%)

ACAD Acadia
$44.32 /

+0.87 (+2.00%)

ABBV AbbVie
$97.13 /

+0.17 (+0.18%)

  • 15
    Jul
  • 30
    Jan
  • 18
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$78.93 /

+1.82 (+2.36%)

LLY Eli Lilly
$160.63 /

+1.25 (+0.78%)

BIIB Biogen
$286.08 /

+13.75 (+5.05%)

ABBV AbbVie
$97.13 /

+0.17 (+0.18%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$78.93 /

+1.82 (+2.36%)

LLY Eli Lilly
$160.63 /

+1.25 (+0.78%)

BIIB Biogen
$286.08 /

+13.75 (+5.05%)

ACAD Acadia
$44.32 /

+0.87 (+2.00%)

ABBV AbbVie
$97.13 /

+0.17 (+0.18%)

MRK Merck
$78.93 /

+1.82 (+2.36%)

LLY Eli Lilly
$160.63 /

+1.25 (+0.78%)

BIIB Biogen
$286.08 /

+13.75 (+5.05%)

ABBV AbbVie
$97.13 /

+0.17 (+0.18%)

Conference/Events
Alzheimer's Association to hold a virtual conference » 08:51
07/27/20
07/27
08:51
07/27/20
08:51
ABBV

AbbVie

$96.96 /

-1.06 (-1.08%)

, ACAD

Acadia

$43.45 /

-0.34 (-0.78%)

, ALEC

Alector

$22.09 /

-0.22 (-0.99%)

, BIIB

Biogen

$272.33 /

-6.46 (-2.32%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$159.38 /

-2.14 (-1.32%)

, MRK

Merck

$77.11 /

-0.94 (-1.20%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Alzheimer's…

Alzheimer's Association International Virtual Conference: AAIC Virtual 2020 will be held on July 27-31. Webcast Link

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$77.11 /

-0.94 (-1.20%)

LLY Eli Lilly
$159.38 /

-2.14 (-1.32%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$272.33 /

-6.46 (-2.32%)

ALEC Alector
$22.09 /

-0.22 (-0.99%)

ACAD Acadia
$43.45 /

-0.34 (-0.78%)

ABBV AbbVie
$96.96 /

-1.06 (-1.08%)

ABBV AbbVie
$96.96 /

-1.06 (-1.08%)

07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
ACAD Acadia
$43.45 /

-0.34 (-0.78%)

07/27/20 Canaccord
Acadia pullback a buying opportunity, says Canaccord
07/21/20 Oppenheimer
Acadia price target lowered to $42 from $53 at Oppenheimer
07/21/20 RBC Capital
Acadia price target lowered to $55 from $61 at RBC Capital
07/21/20 Citi
Acadia price target lowered to $63 from $69 at Citi
ALEC Alector
$22.09 /

-0.22 (-0.99%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
BIIB Biogen
$272.33 /

-6.46 (-2.32%)

07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
07/27/20 Morgan Stanley
Biogen upgraded to Overweight from Underweight at Morgan Stanley
07/23/20 BMO Capital
Biogen price target lowered to $280 from $317 at BMO Capital
07/22/20 Wells Fargo
Biogen price target raised to $324 from $311 at Wells Fargo
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
08/05/19 Citi
Eisai upgraded to Neutral from Sell at Citi
LLY Eli Lilly
$159.38 /

-2.14 (-1.32%)

07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
MRK Merck
$77.11 /

-0.94 (-1.20%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
RHHBY Roche
$0.00 /

+ (+0.00%)

07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
07/24/20 Barclays
Barclays backs Overweight on Roche after 'soft' Q2
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$77.11 /

-0.94 (-1.20%)

LLY Eli Lilly
$159.38 /

-2.14 (-1.32%)

BIIB Biogen
$272.33 /

-6.46 (-2.32%)

ALEC Alector
$22.09 /

-0.22 (-0.99%)

ACAD Acadia
$43.45 /

-0.34 (-0.78%)

ABBV AbbVie
$96.96 /

-1.06 (-1.08%)

  • 15
    Jul
  • 30
    Jan
  • 18
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$77.11 /

-0.94 (-1.20%)

LLY Eli Lilly
$159.38 /

-2.14 (-1.32%)

BIIB Biogen
$272.33 /

-6.46 (-2.32%)

ABBV AbbVie
$96.96 /

-1.06 (-1.08%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$77.11 /

-0.94 (-1.20%)

LLY Eli Lilly
$159.38 /

-2.14 (-1.32%)

BIIB Biogen
$272.33 /

-6.46 (-2.32%)

ACAD Acadia
$43.45 /

-0.34 (-0.78%)

ABBV AbbVie
$96.96 /

-1.06 (-1.08%)

MRK Merck
$77.11 /

-0.94 (-1.20%)

LLY Eli Lilly
$159.38 /

-2.14 (-1.32%)

BIIB Biogen
$272.33 /

-6.46 (-2.32%)

ABBV AbbVie
$96.96 /

-1.06 (-1.08%)

Hot Stocks
Alector doses first patient in Phase 3 INFRONT-3 trial of AL001 » 08:33
07/24/20
07/24
08:33
07/24/20
08:33
ALEC

Alector

$22.31 /

-0.41 (-1.80%)

Alector announced dosing…

Alector announced dosing of the first patient in its pivotal Phase 3 clinical trial, named INFRONT-3, evaluating AL001 in people at risk for or with frontotemporal dementia due to a progranulin gene mutation. AL001 is the company's wholly owned, investigational human monoclonal antibody designed to modulate progranulin, a key regulator of immune activity in the brain. Frontotemporal Dementia is a rapidly progressing and severe form of dementia found most frequently in people less than 65 years old at the time of diagnosis. It affects 50,000 to 60,000 people in the United States and roughly 110,000 in the European Union. There are multiple heritable forms of FTD, and FTD-GRN patients represent 5% to 10% of all people with FTD. There are currently no approved treatments options available for FTD. The randomized, double-blind, placebo-controlled trial will enroll up to 180 FTD-GRN mutation carriers across approximately 50 sites in the United States, Europe and Australia. Symptomatic and pre-symptomatic participants will be randomized to receive AL001 or placebo intravenously every four weeks. Participants will also be given the option to continue receiving treatment in an open-label extension study. The primary endpoint of the pivotal Phase 3 trial is to measure the effect of AL001 on clinical decline by utilizing the CDR plus NACC FTLD-SB assessment, which evaluates clinical impairments in behavior, language, memory, judgment, and functional activities in trial participants. In addition, the trial will assess secondary clinical endpoints, multiple biomarkers and safety.

ShowHide Related Items >><<
ALEC Alector
$22.31 /

-0.41 (-1.80%)

ALEC Alector
$22.31 /

-0.41 (-1.80%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
ALEC Alector
$22.31 /

-0.41 (-1.80%)

  • 15
    Jul
  • 30
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.